Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.
Cycling Weekly on MSN23h
Cycling and your pelvic floor: What every rider needs to knowCycling is an incredible sport with numerous health benefits, but spending long hours in the saddle can take a toll on an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback